Administration, Ophthalmic

Known as: Administrations, Ophthalmic, Ophthalmic Administration, Administrations, Ocular 
Application of pharmaceutically active agents on the tissues of the EYE.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1953-2018
0102019532017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Pharmacologic treatment of diabetic retinopathy via eyedrops could have advantages but has not been successful to date. We… (More)
Is this relevant?
2006
2006
The purpose of this study was to design microspheres combining sustained delivery and enhanced intracellular penetration for… (More)
Is this relevant?
2004
2004
AIM Eye drops are the most used dosage form by the ocular route, in spite of their low bioavailability. Due to their properties… (More)
Is this relevant?
2003
2003
Diagnostic tests for Alzheimer's disease (AD) involving tropicamide blockade of cholinergic oculomotor functions were examined in… (More)
Is this relevant?
2002
2002
The ocular pharmacokinetics of latanoprost (13,14-dihydro-17-phenyl-18, 19,20-trinor-PGF(2alpha)-isopropyl ester; Xalatan… (More)
Is this relevant?
2002
2002
BACKGROUND Corticosteroids have been the only effective topically administered treatment for severe vernal keratoconjunctivitis… (More)
Is this relevant?
1997
1997
The bioavailability of acyclovir to the ophthalmic epithelium is low and when the drug is administered in ophthalmic ointment it… (More)
Is this relevant?
1997
1997
• Background: It has been shown that intravitreal injection of NGF inhibits ganglion cell degeneration after optic nerve… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 4
Is this relevant?
1996
1996
Purpose. Nanocapsules composed of an oily core (Migliol 840) (MG) surrounded by a poly-ε-caprolactone (PECL) coat were evaluated… (More)
Is this relevant?
1993
1993
To investigate the potential of polymeric nanocapsules for ocular delivery of beta-blockers, several formulations of… (More)
Is this relevant?